GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” that provides key data, information and analysis of the major trends and issues in Nanotechnology in Drug Delivery market.
The report provides a comprehensive insight into the role of Nanotechnology in Drug Delivery. The report also provides a detailed analysis of market characterization of nanotechnology in drug delivery market in terms of its market size, segmentation by key geography types and the major market drivers and barriers. The report also talks about the technological trends over the years in use of nanotechnology in drug delivery.
The scope of the report includes -
Detailed overview of Nanotechnology in Drug Delivery in pharmaceutical industry along with their use, efficiency and limitation.
Annualized market data from 2007 and forecast forward till 2016 along with segmentation by geography.
Key market drivers and restraints shaping the Nanotechnology in Drug Delivery market.
Competitive landscape analysis with competitive profiling of leading companies.
Analysis of partnership deals from 2006 to 2010
Analysis of M&A deals from 2005 to 2010 along with segmentation by value geography and companies.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
Develop better strategies for Nanotechnology in Drug Delivery market by understanding the market dynamics.
Develop market-entry and market expansion strategies by identifying the key development area
Understand the factors shaping the Nanotechnology in Drug Delivery
For understanding the technological trends in the market.
Identify the key players best positioned to take the advantage of the opportunities in the global market.
Exploit partnership and acquisition opportunities by identifying the products that could fill the portfolio gaps.
Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/3170
Table of Contents
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Nanotechnology in Drug Delivery - Introduction
2.2 GBI Research Report Guidance
3 Application of Nanotechnology in Drug Delivery
3.1 Current Applications of Nano-enabled Drug Delivery
3.1.1 Nano-engineered drugs
3.2 Future Applications of Nano-enabled Drug Delivery
3.2.1 Gene and Vaccine Delivery
3.2.2 Controlled-Release Devices
3.2.3 Increased Biocompatibility
3.2.4 Improved Drug Bioavailability and Solubility
3.2.5 Applied Diagnosis, Etiology, Prognosis and Therapy (ADEPT)
3.2.6 Tissue Specific Delivery
4 Nanotechnology in Drug Delivery - Case Studies
4.1 Abraxis Bioscience, Inc. - Paclitaxel-Albumin Nanoparticles (Abraxane)
4.2 Nanospectra Biosciences- AuroShell Particles
4.3 Calando Pharmaceuticals, Inc. - RONDEL Technology
4.4 Starpharma Holdings, Ltd. - Dendrimer-Based VivaGel
4.5 Mersana Therapeutics: Fleximer - Camptothecin Conjugate
4.6 Elan Corporation - NanoCrystal Technology